A Study to Evaluate Pumitamig Versus Durvalumab Following Concurrent Chemoradiation Therapy in Participants With Unresectable Stage III Non-small Cell Lung Cancer (NSCLC) (ROSETTA Lung-201)

Part of paid clinical trials in Daphne, Alabama.

Sponsor
Bristol-Myers Squibb
Study ID
NCT07361497
Phase
PHASE3
Status
Recruiting
Apply to this trial

Conditions

  • Non-small Cell Lung Cancer (NSCLC)

Eligibility Criteria

Sex
ALL
Age
18 Years - N/A
Healthy Volunteers
Not accepted

Interventions

  • Pumitamig — DRUG
    Specified dose on specified days
  • Durvalumab — DRUG
    Specified dose on specified days

Study Details

A study to evaluate Pumitamig versus Durvalumab following concurrent chemoradiation therapy in participants with unresectable stage III Non-small Cell Lung Cancer (NSCLC)

Key Dates

Start date
Mar 16, 2026
Status verified
Jun 2026
Primary completion
Sep 18, 2030
Completion
Dec 31, 2033

Study Design

Enrollment
850 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Arm A
  • Active Comparator: Arm B

Primary Outcome Measure

Progression-free survival (PFS) by blinded independent central review (BICR) (per Response Evaluation Criteria in Solid Tumors (RECIST) v1.1) [ Time Frame: Up to 3 years ]

Central Contacts

  • BMS Clinical Trials Contact Center www.BMSClinicalTrials.com
    855-907-3286
    [email protected]
  • First line of the email MUST contain NCT # and Site #.

Locations (38)

FacilityCityStateZIPSite coordinators
Southern Cancer Center PcDaphneAlabama36526
Michael Meshad, Site 0898
111-111-1111
Local Institution - 0780ChandlerArizona85224
Site 0780
Local Institution - 0585GoldenColorado80401
Site 0585
Medical Oncology Hematology Consultants, PANewarkDelaware19713
Jamal Misleh, Site 0896
302-366-1200
Local Institution - 0711OcalaFlorida34474
Site 0711
Local Institution - 0756MariettaGeorgia30060
Site 0756
Local Institution - 0398ChicagoIllinois60637
Site 0398
Local Institution - 0850EvanstonIllinois60201
Site 0850
Illinois Cancer CarePeoriaIllinois61615
Srinivas Jujjavarapu, Site 0897
309-243-3000
Fort Wayne Medical Oncology and HematologyFort WayneIndiana46804
Ahad Sadiq, Site 0317
260-436-0800
Local Institution - 0656LexingtonKentucky40536-0284
Site 0656
Local Institution - 0603BostonMassachusetts02114-2621
Site 0603
Local Institution - 0419DetroitMichigan48201
Site 0419
Minnesota Oncology HematologyMaple GroveMinnesota55369
Daniel Mundt, Site 0322
Local Institution - 0142Saint PaulMinnesota55102
Site 0142
Missouri Cancer AssociatesColumbiaMissouri65201
Caleb Smith, Site 0900
Memorial Sloan Kettering Cancer CenterNew YorkNew York10065
Mark Awad, Site 0606
Local Institution - 0339WestburyNew York11590-
Local Institution - 0909WestburyNew York11590
Site 0909
Local Institution - 0493Winston-SalemNorth Carolina27103
Site 0493
Local Institution - 0923AkronOhio44302
Site 0923
Local Institution - 0412CincinnatiOhio45219
Site 0412
Local Institution - 0359ClevelandOhio44106-5066
Site 0359
Local Institution - 0597ClevelandOhio44195
Site 0597
Local Institution - 0924Mayfield HeightsOhio44124
Site 0924
Oncology Associates Of Oregon, PcEugeneOregon97401
Bo Wang, Site 0895
541-683-5001
Northwest Cancer Specialists, P.C.Happy ValleyOregon97015
Anthony Van Ho, Site 0302
503-885-5411
Local Institution - 0480NashvilleTennessee37203
Site 0480
SCRI Oncology PartnersNashvilleTennessee37203
Melissa Johnson, Site 0240
615-329-7274
Texas Oncology - Amarillo Cancer CenterAmarilloTexas79124
Pankaj Khandelwal, Site 0908
000-000-0000
Texas Oncology-Austin CentralAustinTexas78731
James Uyeki, Site 0857
512-427-9400
Texas OncologyDentonTexas76210
Kartik Konduri, Site 0894
214-370-1000
Local Institution - 0811Fort WorthTexas76104
Site 0811
Local Institution - 0596HoustonTexas77030
Site 0596
Texas Oncology - San Antonio Medical CenterSan AntonioTexas78229
Krishna Alluri, Site 0902
210-656-7177
Texas Oncology - Northeast TexasTylerTexas75702
Sarah Wang, Site 0899
903-579-9800
Blue Ridge Cancer CareChristiansburgVirginia24073
Jerome Goldschmidt, Site 0133
540-381-5291
Virginia Oncology AssociatesNorfolkVirginia23502
John Paschold, Site 0250

Find similar trials in Daphne, AL

By research site
Southern Cancer Center Pc· Daphne, ALLocal Institution - 0780· Chandler, AZLocal Institution - 0585· Golden, COMedical Oncology Hematology Consultants, PA· Newark, DELocal Institution - 0711· Ocala, FLLocal Institution - 0756· Marietta, GA

Related Studies